BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19277400)

  • 21. Self-monitoring of oral anticoagulation therapy in children.
    Paioni P; Kroiss S; Kägi E; Bergsträsser E; Fasnacht M; Bauersfeld U; Schmugge M; Albisetti M
    Acta Haematol; 2009; 122(1):58-63. PubMed ID: 19816011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CoaguChek point-of-care testing prothrombin time monitors.
    Braun SL
    Am J Clin Pathol; 2007 Oct; 128(4):671-2; author reply 672. PubMed ID: 17924500
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment.
    Poller L; Keown M; Ibrahim SA; van der Meer FJ; van den Besselaar AM; Tripodi A; Jespersen J; Meijer P; Kluft C;
    Clin Chem; 2006 Oct; 52(10):1843-7. PubMed ID: 16998117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An outpatient clinic measure and control system for anticoagulation levels, CoaguChek XS].
    Romero Guardeño A; Pérez Lucena DA
    Rev Enferm; 2009 Mar; 32(3):211-6. PubMed ID: 19462604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality assessment of CoaguChek point-of-care international normalized ratio monitors: a note of caution.
    Kitchen S; Kitchen D; Jennings I; Woods T; Walker I
    Clin Chem; 2007 Aug; 53(8):1555-6; author reply 1556-7. PubMed ID: 17644796
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting.
    Moore GW; Henley A; Cotton SS; Tugnait S; Rangarajan S
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):287-92. PubMed ID: 17413768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patient education in self management of his treatment].
    Pilloud D; Gavin N; Schnetzler B
    Soins; 2007 Jun; (716 Suppl):S6-10. PubMed ID: 17847594
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of the performance verification of the CoaguChek XS system.
    Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM
    Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material.
    Sølvik UØ; Stavelin A; Christensen NG; Sandberg S
    Scand J Clin Lab Invest; 2006; 66(4):337-49. PubMed ID: 16777762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision and accuracy of point-of-care testing coagulometers used for self-testing and self-management of oral anticoagulation therapy.
    Christensen TD; Larsen TB
    J Thromb Haemost; 2012 Feb; 10(2):251-60. PubMed ID: 22118602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors.
    Meijer P; Kluft C; Poller L; van der Meer FJ; Keown M; Ibrahim S; van den Besselaar AM; Tripodi A; Jespersen J
    Am J Clin Pathol; 2006 Nov; 126(5):756-61. PubMed ID: 17050073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing an optimal therapeutic range for coumarins: filling in the gaps.
    O'Donnell M; Hirsh J
    Arch Intern Med; 2004 Mar; 164(6):588-90. PubMed ID: 15037485
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of a home international normalized ratio monitoring program: strategic approach and evaluation.
    Jones S; Newall F
    J Paediatr Child Health; 2013 Sep; 49(9):E357-60. PubMed ID: 23662793
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
    Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral anticoagulation. What is vital in blood coagulation management? (interview by Dr. Judith Neumaier)].
    Sucker C
    MMW Fortschr Med; 2009 Mar; 151(12):48. PubMed ID: 19475860
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral anticoagulant treatment].
    Melis Tormos E
    Rev Enferm; 2009 May; 32(5):48-54. PubMed ID: 19552155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quick Time].
    Emile C
    Rev Infirm; 2007 Sep; (133):41-2. PubMed ID: 17941529
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oral anticoagulation control in a cardiac surgery ward].
    Melis Tormos E
    Rev Enferm; 2008 Sep; 31(9):8-12. PubMed ID: 19007028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External quality assessment for prothrombin time/international normalised ratio using point-of-care devices: split-sample or conventional external quality assessment using control samples?
    Kitchen D; Murray E; Kitchen S; Jennings I; Fitzmaurice D; Woods T; Walker I
    Scand J Clin Lab Invest; 2007; 67(7):673-5; author reply 676-7. PubMed ID: 17963156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.